FastSaying

Earnings growth has been surprisingly low for drug stocks and there is more of that to come as we go through a cycle of patent expirations, ... But I think the stocks are close to being washed out and if you have patience they will do quite well over a longer period of time.

Daniel Boone

Related Quotes

Earnings growth has been surprisingly low for drug stocks and there is more of that to come as we go through a cycle of patent expirations. But I think the stocks are close to being washed out and if you have patience they will do quite well over a longer period of time.
— Daniel Boone
DrugEarningsGrowth
There have been a lot of skeptics, and that's why HP sells at a discount. But there were very low expectations for everything outside of printing so the risk/reward scenario is favorable,
— Daniel Boone
DiscountLowSells
There have been a lot of skeptics, and that's why HP sells at a discount. But there were very low expectations for everything outside of printing so the risk/reward scenario is favorable.
— Daniel Boone
DiscountLowSells
These stocks historically have price-to-earnings ratios in the high teens to low 20s, an I expect they'll return to that level.
— Scott Stember
EarningsExpectHigh
Target is a great example of an extraordinarily fine company with above average growth rate, ... Most consumers know Target. But maybe they don't know how socially responsible they are.
— Daniel Boone
AboveAverageCompany